Skip to main content
ACIU logo

AC Immune SA

ACIUNASDAQHealthcareBiotechnology

$2.31Today:- (-)1Y −11.03%

As of Oct 26, 2026 close

Market cap
$243.13M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.10$4.00
Volume (live)
-
Avg. volume (3M)
188.78K

AC Immune SA (ACIU) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), AC Immune SA reported total assets of CHF 154.43M and total liabilities of CHF 109.49M. Shareholders' equity was CHF 44.93M, down 60.0% from CHF 112.27M a year earlier. Total debt stood at CHF 4.55M against CHF 91.41M in cash and short-term investments, a net cash position of CHF 86.87M. That puts debt-to-equity at 0.10, compared with 0.05 a year earlier.

AC Immune SA Balance Sheet Analysis

Values in millions CHF

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for AC Immune SA (ACIU) - Annual data in millions CHF
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents26.8336.2878.4931.5982.22160.89193.59156.46124.38
Short-Term Investments64.69129.2124.5591.00116.0065.0095.0030.000.00
Cash & Short-Term Investments91.41165.49103.05122.59198.22225.89288.59186.46124.38
Accounts Receivable1.341.1014.800.411.401.591.404.103.72
Inventory0.000.000.000.000.000.000.000.00-1.36
Other Current Assets3.975.416.445.103.024.282.792.361.44
Total Current Assets96.83171.99125.15128.09202.63231.77292.77192.93129.53
Non-Current Assets
Property, Plant & Equipment (Net)6.548.096.887.078.036.646.173.322.35
Long-Term Investments0.580.000.360.000.360.000.300.300.13
Intangible Assets50.4750.4250.4250.4250.420.000.000.000.00
Other Non-Current Assets0.000.420.360.360.360.330.000.000.00
Total Non-Current Assets57.5958.9257.6657.8458.816.976.483.632.48
Total Assets154.43230.91182.81185.94261.44238.74299.25196.56132.01
Current Liabilities
Accounts Payable2.072.661.680.932.002.180.141.981.09
Short-Term Debt0.851.030.670.550.570.441.090.330.00
Accrued Liabilities8.0712.1011.099.4216.7411.09---
Deferred Revenue83.710.000.140.000.720.004.480.350.36
Other Current Liabilities8.0797.1511.0910.0017.4511.3911.8010.428.31
Total Current Liabilities94.80100.8413.5811.4820.0314.0217.5113.089.75
Non-Current Liabilities
Long-Term Debt3.694.402.832.252.341.781.810.190.89
Other Non-Current Liabilities8.6613.405.773.217.107.467.495.674.53
Total Non-Current Liabilities14.6917.818.605.479.449.249.305.855.42
Total Liabilities109.49118.6422.1716.9529.4623.2626.8118.9315.17
Stockholders' Equity
Common Stock2.262.232.091.801.791.541.441.351.15
Retained Earnings-439.52-368.24-316.20-264.02-200.94-132.85-75.52-121.88-72.61
Accumulated Other Comprehensive Income0.010.00-0.050.010.00-0.00-3.54179.35
Treasury Stock0.220.220.110.120.12----
Additional Paid-in Capital482.19478.29474.91431.20431.25346.79346.53298.15188.30
Shares Outstanding101.74100.4199.2083.6283.48----
Total Stockholders' Equity44.93112.27160.64168.99231.98215.48272.44177.62116.84
Total Liabilities & Equity154.43230.91182.81185.94261.44238.74299.25196.56132.01

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AC Immune SA Balance Sheet

How much debt does AC Immune SA have?

AC Immune SA had total debt of CHF 4.55M as of Dec 31, 2025, against CHF 91.41M in cash and short-term investments. Its debt-to-equity ratio was 0.10. Total debt was CHF 5.43M a year earlier.

What are AC Immune SA's total assets?

AC Immune SA reported total assets of CHF 154.43M as of Dec 31, 2025, down 33.1% from CHF 230.91M a year earlier. Total liabilities were CHF 109.49M.

What is AC Immune SA's shareholders' equity?

AC Immune SA's shareholders' equity was CHF 44.93M as of Dec 31, 2025, or about CHF 0.44 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition